Mimedx (MDXG) EPS (Diluted) Growth (1y) (2012 - 2024)
Mimedx (MDXG) EPS (Diluted) Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,091.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -83.75% |
| Sep 30, 2024 | -10.37% |
| Jun 30, 2024 | 82.27% |
| Mar 31, 2024 | 290.54% |
| Dec 31, 2023 | 326.33% |
| Sep 30, 2023 | 166.57% |
| Jun 30, 2023 | 158.65% |
| Mar 31, 2023 | 70.70% |
| Dec 31, 2022 | 668.66% |
| Sep 30, 2022 | -151.80% |
| Jun 30, 2022 | -272.68% |
| Mar 31, 2022 | -20.16% |
| Dec 31, 2021 | 92.41% |
| Sep 30, 2021 | 92.62% |
| Jun 30, 2021 | 62.06% |
| Mar 31, 2021 | -100.84% |
| Dec 31, 2020 | -138.63% |
| Sep 30, 2020 | -524.17% |
| Jun 30, 2020 | 51.34% |
| Mar 31, 2020 | 64.06% |